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ARSENICAL DERMATITIS. 
A study of its causes, with a review of 96 cases occur- 
ring during treatment at the Salford Municipal Clinic. 
"The skin is the largest and most exposed organ of the 
body. It and the lungs, therefore, share two common 
weaknesses: each is always open to irritation by ex- 
ternal attack, as well as by internal toxins." 
(Prosser - White, Occupational 
Affections of the Skin. 1928) 
Historical. 
When Columbus wearily warped his travel- stained 
vessels at Palos, on the Ides of March, 1493, he brought 
with him the news of the discovery of America. As the 
immediate evidence of the gallantry of his crews, there 
was introduced into a factious and warring Europe a new 
peril, which was to add to the armoury of nations a weapon 
which not all the mamelons and javelins of the contentious 
armies could equal in effectiveness, a new disease. Its 
very novelty was its chief menace, and with the passage 
of time although the problem of diagnosis and classification 
has been solved, there still remains the greater problem 
of its treatment. Since the first therapeutic gropings 
of the early syphilidators, which led to the foundation 
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of the modern attack on the disease, until the present 
day, the variety of the drugs has only been exceeded by 
the variety in the methods of applying them. The result 
of the patient endeavour of these four centuries, has 
been to establibh the drug Arsenic in the first place 
in the armamentarium of the syphilographer. While it 
does not stand in relation to the treatment of syphilis 
as Cinchona Bark does to malaria, yet its proved eff i- 
ciency and its ease of administration has entitled it to 
the distinction of being called "the Golden Drug of 
Syphilis ". 
The extensive use of Arsenic as a poison has given 
to the toxicologist and the general public a knowledge 
of its lethal action on the body. Its therapeutic use 
has also been followed by ill -effects and with its 
universal use in the treatment of syphilis, the knowledge 
and understanding of these ill- effects becomes increasingly 
important. 
Bechet (1) in a review of the history of the arseni- 
cal eruptions, mentions that Fowler was the first to 
record the frequency of urticarial eruptions after the 
use of his Liquor Potassii Arsenitis, and in 1857 Devergie 
was the first to realise tnat cutaneous lesions might 
result from the internal administration of arsenic. TYe 
lesions he called "taches arsenicales" were examples of 
arsenical pigmentation. Erasmus Wilson drew attention 
to the local and systemic poisoning from dyes containing 
.arsenic, and Jonathan Hutchinson described arsenical 
keratosis and arsenical cancer. 
Hutchinson (2) noticed the occurrence of Herpes 
Zoster following the use of arsenic, and further he 
mentions that patients who were being given the drug 
tended to show other signs of cutaneous and systemic 
intolerance, in the form of a dry, earthy skin, and a 
dull eye. lie demonstrates the recurrent eruption then 
known as "arenical eczema ", and states that the herpetic 
eruption of arsenic was not usually a symmetrical lesion. 
In confirmation of the effect of the internal administra- 
tion of arsenic on the nervous system, he describes a 
case of peripheral neuritis, and frequently mentions the 
lesions of herpes which follow these signs of intolerance. 
In another volume he illustrates the development of 
Arsenical Keratosis and'krsenic- Caner" in patients on 
long -continued arsenic. He describes typical keratoses 
of the palms and soles in such a case, and a case of 
arsenical pigmentation. 
Pharmacology of Arsenic in Relation to its Cutaneous 
Toxicity. 
Cushny (3) in his description of the action of 
Arsenic upon the skin, states that it accelerates growth 
and proliferation of epithelium, and in severe cases this 
goes on to atrophy and degeneration. The skin eruptions 
are due directly to the action of arsenic on the cutaneous 
structures, and discussing chronic arsenical poisoning, 
he mentions that these occur in various forms in the second 
phase of the toxic process. In prolonged poisoning the 
skin lesions simulate almost any form of skin disease. 
Later stages of the poisoning process are characterised 
by disturbances of sensation and motion in localised 
areas, generally in the hands and feet in the form of 
peripheral neuritis. 
The skin disturbances take the form of papules, 
either vesicular or erythematous, a flaking of the epidermis 
and keratosis. Pigmentation is also noted and conversely 
depigmentation. 
ProsserWhite (Lt) quotes Fischer and Schmidt s ex- 
periments on the excretion of certain substances which 
when introduced into the body are voided with the skin 
secretions. Fischer(5) states that this excretion is 
responsible for the production of dermatoses, which he 
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calls "excretion dermatoses", and they are characterised 
by proliferation of the cells of the horny layer, and 
those lining the follicles, the falling out of the hair, 
and ultimately of cancer. 
Butler (6) describes the effect of arsenic in 
chronic poisoning (even with minute doses) on the nervous 
system, which is markedly affected, particularly the 
peripheral nerves, both motor and sensory. With prolonged 
use arsenic tends to accumulate to a greater extent in 
nervous than in other tissues. Butler goes on to say that 
chronic arsenical poisoning is followed by eruptions, 
herpes, pigmentations, increased growth of hair and 
nails, paraesthesiae, peripheral neuritis, and neuralgic 
pains. 
Kolmer (7) considers that the action of arsenic on 
the skin in the production of the "arsenical dermatoses" 
lies in its action on the capillaries, which he classes 
as primary toxic effects. 
The Distribution 
The distribution of the arsenic in the various tissues 
of the body is of prime importance, since the inter - 
dependability of function of the different structures 
of the human frame is a primary physiological fact. Stokes ( 
in a table of the comparative distribution of armeno- 
benzole compound after injection, quotes the findings 
of Boegtlin and Clausen and Jeans, which give the 
arsenic content in the different tissues in the following 
order: 
Urine, bile, liver, spleen, stomach, intestinal 
tract, blood, lungs, heart, kidneys and skin. 
It is noteworthy that the skin is mentioned last. 
He states that the high arsenic content of the urine 
and bile shows the rapidity with which the kidney and 
liver deal with the drug, and the fact that the kidneys 
show, next to the skin, the lowest content of arsenic, 
points to the rapidity with which this organ eliminates 
the drug. 
Kolmer (9) describing the distribution and storage 
of the arsphenamines after injection, states that the 
arsenic has been found largely in the liver, spleen and 
lungs. 
Bulmer (10) found that after the intravenous injection 
of the arsphenamines in rabbits, the arsenic was found 
chiefly in the liver, lungs, kidneys and long bones. 
In further observations of the effect of arsenic 
on rabbits Osborne, Putnam and Hitchcock (11) based their 
findings on micro- chemical studies of the arsenic in the 
tissues, as they state that a quantitive estimation of 
the drug from various sites is no indication of the 
storage of the drug. The arsenic is deposited in the 
tissues as the trisulphide. Thyobserved that in rabbits 
which had received a course of eight therapeutic in- 
jections of arsenic: 
1. The drug is rapidly metabolised in 
the liver. 
2. No evidence was present that there 
was any appreciable amount of storage 
in the tissues. 
3. There was a rapid elimination of the 
drug. 
They went on to show, however, that there was storage 
of arsenic in the liver in cases where a fatal dose was 
given, but that other tissues did not show any great 
degree of retention. The kidneys especially showed very 
little storage, and they concluded from this that the 
kidneys played a minor role in the elimination of the 
drug. The intestinal tract, the stomach, colon and 
small intestine were the greatest factors in the elimi- 
nation, and that no other organs were involved in the 
storage of arsenic, except when it occurred in and around 
the smaller blood vessels. 
Fordyce, Rosen and Myers (12) have shown that arsenic 
has a marked affinity for epithelial cells. 
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Elimination of Arsenic. 
The study of the elimination of the drugs used in 
the treatment of syphilis depends upon the "usability" 
(Burke) of the drug, i.e. the amount which can be taken 
up by the body and converted from the therapeutically 
inactive form in which it is injected (as proved by in 
vitro tests) into the potent oxide of the organic arseni- 
cal compound. The rapidity with which this is accomplished 
is one factor, another is the rapidity with which the 
drug is passed out of the system either as the "oxide" 
or the therapeutically inactive ta.rsenites and arsenates. 
This latter factor is of special interest to the syphilo- 
grapher, in his assessment of the particular line of 
treatment of any particular patient as it concerns him 
greatly if his patient cannot tolerate the generally 
accepted efficient dose of the drug chosen. He cannot 
assess the amount of wastage which occurs with the 
elimination of the therapeutically active portion of the 
drug. 
Kolmer (13) in his studies of this aspect of the 
administration of the arsphenamines in the treatment of 
syphilis, has shown that the rate of absorption of the 
arsphenamine series depends upon the route of administration. 
The intravenous ,route is favoured with a rapid rate 
of absorption, but it is offset by a greater rate of 
elimination, and consequent shorter period of therapeutic 
activity, and in addition toxic effects are more likely 
to occur. 
after intramuscular injection, on the other hand, 
the rate depends upon the amount of tissue injury, the 
greater the tissue injury the slower the absorption. 
By whatever method the drug is administered, the 
ultimate fate is the same. lifter an intravenous in- 
jection the blood receives all the drug, and with a 
varying interval, after intramuscular injection it 
eventually passes almost in its entirety into the blood 
stream, either via the lymph channels, or by being 
directly absorbed at the point of entry by the blood 
itself. Little or none is fixed by the tissues at 
site of injection. 
Disappearance of the arsenic from the blood occurs 
in a very variable manner. It has been shown by Fordyce, 
Rosen and Myers (14) that this variation is due to per- 
sonal idiosyncracy or predisposition to intoxication, 
and also upon the rate of excretion. In certain indivi- 
duals examination of the blood immediately after an 
injection revealed that from 37.9% to 66.1% of arsenic 
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had already disappeared from the blood -stream. 
Elimination in the urine was first studied by Abelin 
in 1911, and he developed a method for the detection of 
arsenic by the diazo colour reaction. Numerous ob- 
servers have used his method, or devised modifications 
of it, and have reported on the rate of elimination. In 
spite of a general agreement that the test was not ex- 
tremely accurate, it was almost unanimously discovered 
that arsenic began to appear in the urine within five 
minutes and that excretion went on for twenty -four hours. 
Lloyd and Lloyd (15) in a contribution on the urinary 
excretion of Novarsenobillon, noted that the excretion 
of arsenic did not proceed evenly. In general there was 
a maximum elimination in the first few hours, followed 
by a gradual diminution in the amount of arsenic in the 
succeeding 12 -15 hours. It was not claimed, however, 
that the Lloyd's modification of Abelin's test demonstra- 
ted the cessation of the eliminatory process, for by 
other means it was proved that arsenic was present in 
the urine for some considerable time afterwards. It was 
noticed also that the patients themselves showed varia- 
tions in their capacity for elimination, for in some cases 
there was no elimination in the first twenty -four hours, 
while in others the presence of arsenic was demonstrable 
up to several days. 
They were able to show that a close association 
existed between inefficient urinary elimination and the 
development of toxic effects, for in 17 out of 34 cases 
of major or minor complications arising out of the toxic 
nature of the drug, defective urinary elimination was 
present. 
The discovery that large amounts of arsenic were 
present in the faeces led to the discovery that the 
bile was the vehicle in which the greatest amount of 
arsenic was eliminated. It was found later that from 
three to five times as much arsenic is to be recovered 
from the faeces than from the urine. The time for the 
appearance of the drug in the bile is however later than 
in the case of the urine, being three or four days after 
an injection of either "606" or it 914" preparation. 
Some investigators showed that the quantity increased 
with each succeeding injection, and attributed this to 
the fact that the liver bore the brunt of the storage when 
the quantity of drug was in excess of that which the 
body was able to metabolise. 
The Intestinal Mucosa is also concerned in the 
elimination of arsenic. Analyses have shown the presence 
of arsenic in those tissues and arsenic has been de- 
monstrated as the cause of cloudy swelling and fatty 
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degeneration of the lining cells, as well as hyperaemia 
of the submucosa. 
To conclude, the various secretions which share in 
the elimination of the drug are the saliva, the milk, the 
perspiration, and finally the vomitus, found in a case 
who vomited four hours after an injection of arsphenamine 
intravenously: but this was due more to regurgitation of 
bile than from actual excretion by the gastric mucosa. 
Variation in the Rate of Elimination. Voegtlin and 
Thompson (quoted by Kolmer (16)) found considerable 
variation in the excretion of arsenic in different rats, 
after intravenous injection with various organic arseni- 
cals. These variations occurred not only in animals 
with impaired renal function, but also in those whose 
kidneys were normal. They showed also that the pentavalent 
arsenicals were excreted more rapidly than the trivalents. 
This fluctuation in the rate of excretion was evidently 
an individual variation, and the authors believe that 
there is no reason to doubt that these fluctuations occur 
in the human being, especially when his eliminatory 
mechanism is still further affected by his disease. 
Variation in the chemical and physical constitution 
of the arsenical preparations used in the treatment of 
syphilis was also studied by these authors, and they 
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concluded that the difference in the rate of excretion, 
toxicity and therapeutic activity of the various trivalent 
arsenicals was due to the difference in their physical 
properties. Kolmer (17) in commenting upon the work 
of Voegtlin and Thompson mentions their findings that 
arsphenamine is eliminated largely by the liver in the 
bile, and that neoarsphenamine and atoxyl are chiefly 
excreted by the kidneys. He submits the hypothesis that 
by relieving the strain on one already overloaded elimi- 
natory organ, it is possible that the body tolerates 
another form of the drug, which calls into play an en- 
tirely different route. 
Histolotg. 
In 1905 Justus (18) described a method for the micro- 
chemical detection of arsenic in the tissues,and by its 
means he found that the deposition of arsenic occurred 
around the nucleus in the cell cytoplasm. The organs 
chiefly affected were the skin, kidneys, liver and in- 
testines, and that the deposits were finer in the kidney 
and intestine, and coarser in the muscles, coil glands 
and epidermis. 
Brunnauer (19) saw the deposition of arsenic tri- 
sulphide as fine, rounded, prolongated granules, yellow 
brown in colour; and practically all of it was situated 
extracellularly. He was unable to say that any of it 
was definitely intracellular. 
Osborne (20) using a modification of Brunnauer's 
method, noted the characteristics of arsenic trisulphide 
in the tissues, and gave a cnemical proof of the identity 
of the arsenic. His researches were concerned with the 
action of the pentavalent forms of the drug, the materials 
used being potassium arsenite (Fowler's solution), solu- 
tion of arsenious acid and mercuric iodide (Donovan's 
solution), arsenic acid,sodium and iron cacodyllate. None 
of the patients had received the trivalent arsenicals, 
such as the arsphenamines. 
In describing Keratosis he made the fóllowing ob- 
servations: 
1. The arsenic (as the trisulphide) was evenly dis- 
tributed in the horny layer between the cells, none 
being intracellular. It was not only present in the 
keratosis but also in the corneum of the normal skin 
surrounding the keratosis, but to a lesser degree. 
2. The arsenic was present in the stratum granulosum 
and stratum spinosum, down to and including the, basal 
layer. The deposits were particularly marked surrounding 
the areas of necrosis. 
3. The area of greatest deposit was in the basal layers 
of the epidermis and in the papillae of the corium, 
especially under the areas of necrosis. 
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4. A small amount of arsenic was present in the inter- 
cellular spaces, around the coil glands, but not in the 
coil glands themselves. It was evenly distributed 
throughout the walls of the ducts as in the epithelium, 
and very little was seen in the lumen of the ducts. 
Commenting on a case described by Brunnauer, in which 
there was an associated hyperidrosis, and in which 
arsenic was found in the coil -glands and ducts, in ad- 
dition to the papillae and epidermis, he states that the 
bulk of the arsenic is apparently deposited in the areas 
of greatest vascularity and gradually passed out intracel- 
lularly. In a case of his o,mri, in which there was hyperi- 
drosis together with keratosis, he saw arsenic in the 
coil -glands, but states that they need not necessarily 
be involved. 
The mechanism of the production of arsenical kera- 
toses would seem to be the speeding -up of the kera- 
tinization cycle, by the deposition of an irritant in 
the form of arsenic in the upper corium, papillae, and 
epidermis. 
In a case of Arsenical Pigmentation the summary of 
the pathological findings was: 
1. A general thickening of the epidermis, owing to an 
increase in the stratum spinosum, stratum granulosum and 
particularly in the horny layer, which in some areas was 
exfoliating. Oedema and inflammatory changes were present 
in the papillae. 
2. Marked perivascular infiltration of the upper part 
of the cutis, of round cells and mast cells, extending 
up into the papillae, with increase and dilatation of 
the small arterioles and lymph spaces, together with 
oedem of the entire upper part of the corium. 
3. Pigment chiefly in the papillae and upper half of 
the corium, located around the arterioles and capillaries 
and in cells arising from them. Infiltration was also 
present around these areas. No pigment was seen 
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intracellularly.' In the epidermis there was an increase 
in pigment in the basal layer, and here and there in 
the stratum spinosum and stratum granulosum, and this 
pigment was granular, situated intracellularly around 
the nucleus. The bulk of the pigment was in the corium. 
The arsenic findings in this case were as follows: 
1. The entire epidermis contained a great. deal of 
arsenic. In the lower layers some of it was apparently 
inside the cells, was evenly distributed, but in no 
relation to the amount of pigment. 
2. The upper half of the corium contained large amounts 
of arsenic, particularly.in the papillae and in the inter- 
cellular spaces surrounding the arterioles. The arsenic 
was separate and distinct from the pigment. 
3. The coil -glands and ducts contained small amounts 
of arsenic, while the sebaceous glands and their ducts 
contained a comparatively large amount. 
L. Considerable amounts were present in the follicles 
and sheaths of the hairs, and in the hairs themselves. 
He concludes with suggesting that the formation of 
pigment is due, not to the reaction of the cells them- 
selves to the irritant action of the arsenic, but to 
the direct action of the arsenic on the melanin to form 
finished pigment. 
The same observer (21) continuing his studies in 
the deposition of arsenic in the skin in cases of arseni- 
cal dermatitis investigated the differences between the 
dermatósss produced by the trivalent arsenicals and 
those resulting from the pentavalents. His study 
comprised a review of cases of varying severity, from 
a simple erythema to a severe, exudative dermatitis, with 
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intense oedema, thickening, fissuring and crusting. 
His findings were as follows: 
1. At no stage in the dermatitis could any but the 
most minute traces of arsenic be found in the epidermis, 
nor could any appreciable amount be found in the sub - 
papillary layer of the corium. 
2. The bulk of the arsenic was deposited deep in the 
corium around the arterioles and capillaries, in the 
walls and lumen of the sweat and sebaceous glands and 
their ducts, in the hair follicles und in the hairs 
themselves. 
3. The amount of arsenic was proportional to the 
severity of the dermatitis, provided the biopsy was 
performed before the administration of sodium thiosulphate. 
4. Section of the normal skin removed from patients 
receiving arsphenamine showed the arsenic in the same 
location, but in relatively small amounts. 
It appears that the actuel distribution of the 
arsenic in the sections was intercellular. 
Summing up, Osborne states that arsenic in the penta- 
valent form shows a definite pred:êliction for structures 
of ectodermal origin, e.g. the sweat and sebaceous glands 
and their ducts, as well as for the hairs and hair 
follicles, and little for the blood vessels in the corium. 
In the case of the trivalent compounds, the arsenic 
had a specialaffinity for the vascular structures, e.g. 
the small arterioles and capillaries below the papillae. 
He remarks that this confirms the clinical opinion that 
arsphenamine is vasculotoxic. (This was first stated by 
Ricker and Knape in experiments on animals.) This special 
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affinity of the pentavalent arsenicals for the ectodermal 
structures may account for the greater affinity of atoxyl 
and tryparsamide for the central nervous system. Clini- 
cally these facts are borne out by the production of 
the neuro- cutaneous types of lesion, e.g. wristdrop and 
optic atrophy, pigmentation, whereas in the typical 
lesions following the trivalent aresenicals, severe 
dermatitis, haemorrhagic, encephalitis and purpura are 
examples of the effect of a vasculotoxin. 
Cannon and Karelitz (22) do not agree with. Osborne. 
In an investigation on the development of vitiligo in 
the skin bf a negro patient after a severe exfoliative 
dermatitis, they were able to demonstrate the absence of 
pigment in the vitiliginous areas. The tissue changes 
were not limited to the cutis, as reported by Osborne. 
In this and two other cases which they examined micro - 
histologically, the epidermis was markedly thickened 
and irregular. Marked changes were present in the rete, 
where acanthosis, disorganisation of the basal -cell layer 
and granular degeneration, as well as disturbances in 
keratinization (hyper- and parakeratosis), Arsenic was 
present in tree tissues as arsenic trisulphide at-all 
stages of the dermatitis, and was to be found throughout 
the epidermis including the horny layer, in the papillary 
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layer of the corium, especially round the capillaries, 
and in the lumen of the sweat glands and their ducts. 
An interesting feature was that different parts of the 
skin in the same patient yielded varying amounts of 
arsenic, when the dried tissue was examined. They state 
that this might well signify nothing more than the 
irregular distribution of arsenic throughout the skin, 
even in closely adjacent areas, possibly contingent 
upon the vascular supply and the cut of the section, 
whether straight or oblique. 
In reviewing the causes of vitiligo, why it should 
appear in some cases and not in others, or why hyper - 
pigmentation should follow arsenical dermatitis and de- 
pigmentation in others, they find that the action of 
the suns and X -rays give the same paradoxical effect. 
They agree with Kyrle (23) who postulated a "congenital 
inferiority of certain circumscribed areas of the skin," 
and suggest that the factor of defective elimination in 
susceptible cases produces a breakdown in the skin. The 
arsenic they describe as the exciting force, but not the 
only one. 
An_,interesting point that they bring out is that the 
size of the dose has little to do with the onset of 
arsenical dermatitis, and that personal idiosyncrasy 
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plays a larger part. 
Kyrie, whose views on the micro -chemical picture 
they quote, says that the primary point of attack is in 
the epidermis. The vascular response (erythema) is a 
reaction in the epidermis to the toxic arsenic. This 
vascular response he holds to be transitory and the 
symptoms recede, but if the irritation is maintained 
chanes take place in the structure of the cells in 
the form of a parakeratosis, to be succeeded by passive 
hyperaemia, exudation of serum and further infiltration 
of cells into the cutis. 
Moser (quoted by Jaffein in (21h)) found that 
cornification and parakeratosis had taken place in two 
cases of terminal lesions resulting from sulphoxalate 
arsphenamine. The most striking change was a vascular 
degeneration. In all the specimens the cutis showed 
perivascular infiltration, especially in the subpapillary 
layers, and most showed cellular infiltrates around the 
sweat glands. 
The vascular damage is clinically demonstrable in 
the obliteration of the radial artery in a case of 
Robinson's (25) and in a case of Kraetzer's with Raynaud's 
disease following chronic arsenic retention. (26) This 
he attributes to the specific action of the arsenic upon 
the endothelium of the arteries and also to the action 
on the sympathetic nervous system. Both factors 
evidently operate to produce the syndrome he describes. 
Ronchese (27) further demonstrated a case in which there 
was definite obstruction to the blood flow in the leg 
in a case which had had an acute dermatitis. 
Theories of the Causation of the Dermatoses. 
With the pharmacology and histo -pathology of the 
skin eruptions as a basis, it is possible to use these 
to arrive at some conception of the causation of them. 
The importance of etiology has been recognised since 
the earliest observers aolrelated cause and effect while 
using arsenic as a therapeutic agent. In 1879 Binz 
and Schultz conceived the theory that the occurrence of 
cutaneous intolerance might be due to the change in the 
body of the pentavalent arsenicals to a trivalent form. 
This induced a tissue instability which manifested itself 
with eruptions on the skin. Since the introduction of 
the organic arsenicals and their universal application 
in the treatment of syphilis, it was noticed that they 
were followed by a variety of skin lesions, and in an 
attempt to arrive at some explanation of these phenomena, 
numerous theories have been advanced. 
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The report of the Salvarsan Committee, 1922, of 
the Medical Research Council gave a general resume of 
the types of dermatitis following the use of salvarsan, 
and attempted to give a line of guidance to those whose 
duty it was to treat syphilis with this drug. Their 
tabulation of observed facts, however, was no more than 
a record of the toxicity of the arsenicals, and they 
did not give a reason why these skin manifestations 
should occur. 
Moore and Keidel (28) in a review of the skin re- 
actions following the organic arsenicals, grouped all 
skin reactions and attributed them directly to the use 
of arsenic. They summarised the causes in two main 
groups: 
1. Simple reactions. These include the urticarias, 
herpes simplex and eryltemata, due to the liberation of 
toxins from latent foci. 
2. Reactions of a graver type, in which the causes may 
be: (a) Damage to the haematopoetic system. Describing 
the blood changes during an acute dermatitis, they found 
that there was present a leucocytosis, together with an 
eosinophilia. Where the reaction increased in severity 
there occurred a state of aplasia of the bone marrow and 
haematogenous tissues, with leucopenia and finally death 
from aplastic anaemia. (b) Where normal excretion is 
interfered with there is a cumulative effect of arsenic. 
.(c) Damage to the liver preventing the normal change of 
arsenic from 's. toxic to a non -toxic form. (d) The 
expression of an anaphylactic phenomenon. 
In a later communication, representing ten years of 
further observation on this subject, they concluded that 
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postarsphenamine dermatitis was the result of direct 
sensitization to arsphenamine, to the products of its 
metabolism, or to a state of general allergic instability 
or hypersensitiveness, not necessarily specific for 
arsphenamine. This sensitization is proved by the re- 
currence of the dermatitis after exhibition of the drug, 
no matter in how small a dose or how long the interval 
between the injections. 
They point out that there is clinical evidence that 
certain cases of dermatitis may be drug -specific, in 
that neoarsphenamine or silverarsphenamine may be given 
without recurrence of the rash. In this connection, a 
similar drug -specificity was noted by the same observers 
in their earlier paper, by Stokes and Cathcart (29) and 
by Ireland. (30 ) 
Milian (31) considered that the influence of toxic 
foci was indisputable, and considered that the onset 
of all skin lesions, not of the exfoliative type, was due 
to the action of toxins from latent bacterial foci, 
stirred into activity by a general lowering of resistance 
temporarily by an injection of arsphenamine. 
The exfoliative type, whether maculo- papular, vesi- 
cular, or scarlatiniform, is definitely due to the action 
of arsenic per se, and he notes particularly the association 
of oedema with these reactions. 
From the "infective" theory of Milian, Stokes and 
Cathcart (32) proposed an allergy or hypersensitiveness, 
not necessarily specific for arsenic, due to continued 
absorption of bacterial proteins from a focus of infection, 
with perhaps the added changes in the blood and tissues 
induced by the injection of the drug, or of the sudden 
liberation of such proteins from a focus following the 
administration of arsenic. There is also present an 
acute shortage of adrenalin, as suggested by Harris (331, 
the effect of which is to inhibit the vaso- dilator mecha- 
nism in the skin. The site of the lesion is determined 
by local application of irritants (e.g. iodine or mercury, 
as suggested by Auer (34)), and increased amounts of bacterial 
protein or antigen brought to these sites of irritation 
or vasodilatation excite the skin cells to inflammation. 
The liver, they consider, plays a part in that in- 
jury to this organ, either by syphilis or by large doses 
of drug, perverts the metabolism of the arsphenamine, 
with the throwing into the blood stream of quantities of 
toxic proteo- chemical compounds. 
Stokes and Kulchar (35) have summarised the "etio- 
logic background" of arsenical dermatitis as having the 
following elements: 
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1. Drug injury to the skin, in addition to other 
organs connected to it in the metabolic processes, 
e.g. the liver. 
2. A general allergic reactivity, due to bacterial 
sensitization, (the infective theory of Milian), or an 
example of the atopic state. 
3. A local sensitivity due to the application of 
nonspecific irritants or from foci of infection in the 
skin itself. 
He stresses the importance of Osborne's findings of 
the vascular injury due to the distribution of arsenic 
around the vessels of the trivalent compounds, and con- 
siders that there is an undoubted element of true specific 
allergy to the drug. They postulate the interaction of 
the drug -allergy and bacterial -allergy, and state that 
either may induce a dermatitis, by influencing the allergic 
mechanism of either sensitization. 
Discussing dermatomycotic infections, they consider 
that these influence the dermatitis process by localising 
the lesions, or by setting up an allergic state for 
themselves and so increasing the general allergic in- 
stability. Whatever non -specific factor may be present, 
the exhibition of arsphenamine aggravates the condition, 
and in the cases where as yet no dermatitic element has 
developed the administration of the drug predisposes the 
patient to the onset of dematitis. 
Other factors are proposed by Lees (36), who found 
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that alcoholism and pre -existing dermatoses predisposed 
to the development of dermatitis. He agrees with Stokes 
that in every case of exfoliative dermatitis a der - 
matoses existed at the commencement of treatment, and 
in patients with the "seborrhoeic diathesis" there 
was a noticeable tendency for eruptions to occur during 
treatment. Lees also considers that nervous, highly 
strung patients are more prone to skin accidents. 
In his conception of the etiology of these dermatoses, 
Schiff (37) is of the opinion that an anaphylactin or 
similar toxic product is produced by injection of the 
drug, which lowef3s the vascular threshold to an unknown 
antigen. The distribution of the arsenic in the skin 
acts as a local irritant, and in addition it finds its 
way into the bone marrow, there to set up changes in the 
haematopoietic function. 
That there is a definite sensitization process at 
work is shewn by the work of Sulzberger (39), Nathan and 
Munk (40) and Frei (38). These observers all found that 
intradermal injection of arsphenamine produced sensiti- 
zation as a rule rather than as an exception. Kauder (4l) 
called attention to the frequency with which infiltration 
of the drug into the tissues during an injection was 
followed by a dermatitis. In Frei's cases, out of 66 
-27- 
patients who had never received arsphenamine, he succeeded 
in sensitizing 8. Schoch (42) reviewed the literature 
of the production of sensitization from percutaneous 
injection quotes the results of Fuhs and Riehl who 
passively sensitized a normal individual with the fluid 
from a vesicle following a percutaneous test. The positive 
reaction also showed itself at a distant point on sub- 
sequent testing, and showed that the whole skin had 
become sensitized. The phenomenon of reactivity at the 
distant point is a proof of the specific allergic nature 
of the process, and means that it depends upon an 
antigen- antibody reaction. In discussing this, Schoch 
suggests that the sensitivity produced by the injection 
of blister fluid was really due to the introduction of 
minute amounts of arsphenamine present in the testing 
dose remaining in the fluid and being re- introduced 
into the subject. Other workers, Templeton and Skilling 
(L3)were unable to produce sensitivity either in human 
beings or experimental animals by the methods of passive 
transference. It would thus appear that the allergic 
state can only be produced by active means. 
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Descriation of the Lesions produced by Cutaneous 
Intolerance to the Arsphenamine $er.ies. 
From the historical survey, it will be seen that it 
was realised that certain affections of the skin were 
characteristic of the effect of arsenic. With the advent 
of the salvarsan series into anti -syphilitic therapeutics, 
additions were being constantly made to the list of these, 
and so much so, that practically any type of dermatoses 
can be produced by the action of these drugs on the 
- cutaneous structures. Ireland 01)0 tabulated these, and 
assessed them in terms of their dermatological equivalents. 
He found that they might be classified as: 
1. Urticaria, indistinguishable from other types of the 
same dermatoses and doubtless a response to cutaneous 
vascular injury. 
2. Erythema Multiforme is not common', and occurs about 
the third day after injection, and he states that the 
cause may be either a peripheral vascular injury or the 
stirring up of a bacterial focus by the injection, with 
the production of a protein or minute emboli. 
3. Lichenoid simulating Lichen Planus. 
4. Herpes, usually labial, but occasionally zosteriform. 
5. Fixed Exanthemata, as noted by Fuchs (5) he considered 
uncommon. 
6. Keratoses, which he also found uncommon. 
7. Ninth -day er thema as described by Milian and Thesleff 
he noTjd as a transien erythema occurring about the ninth 
day after injection and usually passing off without com- 
plications. 
8. Pruritus either a fleeting condition or as a pro- - 
dro üe ói- e'iUliatjve dermatitis. 
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9. Rarer tóxic manifestations, such as Lichen Spinulosus 
Stauffer (46), Psoriasis, Spicca and Bennett (47). 
10. Lastly what he describes as Arsphenamine Dermatitis, 
in which he classes all cases of dermatitis varying from 
the mild, transient pruritic scaling erythema to the 
severe oozing generalised exfoliations. 
He concludes that a survey of the literature reveals 
a diversity of reactions, but the number of fatalities 
are few. 
In a contribution on Herpes Zoster, Wollheim (48 ) 
quoted Butler's views on the action of arsenic on the 
nervous system, particularly the peripheral nerves. 
Under prolonged use the drug tends to accumulate in the 
nervous tissues to a greater extent than in others, so 
much so that Stokes considers that herpes arises from 
the irritation of the peripheral nerves. Lees was of 
opinion that it was a common symptom of "tubing reaction" 
and Stokes agrees with him. Lees also states that the 
occurrence of this lesion is a serious warning of hyper- 
sensitiveness. Wollheim however thinks that the lesion 
is as frequent in cases who have been given their in- 
jections by the syringe, and so far from being a prodromal 
warning of importance, he found that suspension of 
treatment temporarily cleared up the condition, and that 
it never recurred even on further exhibition of the same 




With regard to this condition of the skin, sevdral 
observers have noted and commented upon it. That it is 
a rare condition is generally agreed, an explanation of 
its etiology is varied. Naegeli (49) in describing a 
case which occurred in a naevus, and another in a chronic 
conjunctivitis considered that the localisation of the 
lesion to these areas was due to the hyperaemia and 
vascularisation. Fuchs (50) in the case of a woman with 
a florid secondary syphilide, who noted a brown spot 
on her leg, sharply circumscribed, which itched in- 
tolerably, and which "flared -up" with each injection of 
"914" or on the application of a solution of this drug 
offered no explanation. The essential condition is as 
Fuchs described, namely a sharply circumscribed area, 
which showed an exacerbation of inflammation with each 
injection or when a solution of the same drug is applied 
to it. It is not common, and subsides when treatment 
with the exciting agent is discontinued. The most satis- 
factory explanation is that of Whitfield (51) who points 
out that when the skin is sensitized to a protein, and an 
eczematous lesion develops, the whole body is rendered 
more susceptible to other irritants. In the case of an 
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eczema, itself the product of sensitization to a bacterial 
protein, the area of the eczematous lesion is the precise 
spot at which the response to another irritant will show 
itself. The fact that none of these fixed exanthems ever 
develops into a generalised dermatitis is probably due 
to the maintenance in the particular patient of a 
balance of the antibody- antigen mechanism, the flare -up 
being merely a localisation in the skin at a point where 
a definite weakness exists. 
The study of the pharmacology, distribution and 
elimination of the arsenobenzoles following injection, 
yields the information that from the point of view of 
toxic effects, the organic compounds and the inorganic 
salts are identical in their action, and that therefore 
all the effects are due to the arsenic radical. 
Pick (52) demonstrated the specificity of the ars- 
phenamine molecule in the production of a dermatitis in 
a patient who had become sensitized to both arsenic and 
mercury. A local reaction followed the local application 
of arsphenamin. The reports of the Salvarsan Committee 
of the Medical Research Council in 1922, concluded that 
dermatitis could follow the administration of arsenic 
in whatever form it was given. In so far as deposition 
and storage in the various organs of the body is con- 
cerned, those, structures in which there is the greatest 
metabolic activity show the largest amount of the drug. 
Elimination naturally follows, the presence of arsenic 
beyond the normal amounts inducing an effort on the part 
of the organs to regain their normal state. The kidneys 
are primarily affected, since the blood receives the whole 
of the injection, and as they are the principal regu- 
lators of balance they are easily stimulated to restore 
it. They may be regarded as filters and they possess 
very little tissue to retain any arsenic that is not 
immediately disposed of. The liver, as the principal 
detoxicating agent is then called upon, and hence the 
bile receives a large proportion of the arsenic injected. 
The spleen, as the clearing house of the blood, is bound 
to contain a considerable amount, both from circulating 
arsenic and from the breakdown of humoral elements. It 
would be natural to expect that the lungs, through which 
all the blood must pass, would be found to have retained 
a share in proportion to their size, and that they have 
an undoubted eliminatory function is proved by the well - 
known clinical fact that after an injection of meta - 
arsenargenticum the odour of the patient's breath ad- 
vertises his presence for a considerable time afterwards. 
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Without doubt it is with the liver and kidneys that we 
are most concerned, and efficient functioning of these 
organs is essential for the proper disposition of the 
drug during treatment. The work of the Lloyds showed 
that inefficient urinary elimination was associated with 
the development of toxic effects. Storage in the liver 
occurs with each injection, and it is natural that con- 
stant irritation due to overloading of this organ would 
induce toxic effects, at first in the liver itself, and 
later in the other tissues by the suspension of its 
function. As seen by the work of various authors, where 
the drug is retained, of the tissues results, 
and Diasio (53) in a very complete summing up of the 
causes of dermatitis gave the local irritation of a storage 
overload as one of the main factors. 
It is well -known that the liver can carry on with 
only a very small portion of its substance acting, and 
it is only in those cases where gross damage by gummata 
or by the action of specific liver poisons, of which 
arsenic in certain circumstances is one, that the liver 
function is disorganised, and in these cases e.g. acute 
yellow atrophy, death follows from this reason alone. 
Kolmer found that the long bones stored the drug 
in appreciable amounts, and this may be the foundation of 
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the observed haematopoietic effects noted by Moore. On 
the other hand the leucopenia may develop from the ex- 
haustion of the blood forming tissues due to the intensity 
of the reaction. 
With regard to the deposition of arsenic in the skin, 
it is most natural to expect to find it in or near the 
blood vessels, since it.is carried by the blood stream. 
We agree with Caiinon and Karelitz that the micro- chemical 
picture may be likened to a snapshot of the process, 
since the taking of a continuous picture presents very 
great difficulties. That the pentavalent arsenicals 
show a definite affinity for the ectodermal tissues is 
granted, but that they localise their effects to this 
part of the skin is not entirely proved, for the ob- 
served skin lesions following tryparsamide or Stovarsol 
therapy are in no way different from those following the 
tri- valents. That the exhibition of these drugs is not 
followed by toxic cutaneous manifestations so frequently 
as the trivalent arsenicals, is most probably due to their 
comparatively low arsenic content. The explanation of 
the concentration of arsenic around the blood vessels of 
the corium when trivalent arsenic is used, is that the 
sections were taken at a stage when this had been but 
lately deposited, and had no time to be dispersed, since 
death had taken place. 
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Kyrle's views that the persistence of the irritation 
produces the changes in the skin appears to be the correct 
one, the parakeratoses which have been observed being one 
manifestation, while another, - depigmentation, is due to 
the destructive action on the pigment cells. 
That arsenic is a vasculo -toxin is indisputable. 
Its effect in producing an endarteritis in the cases 
recorded by Robinson and Ronchese, as well as those of 
Meser, show that degeneration does actually follow. It 
is probably one of the chief localising factors in those 
eruptions which are not directly attributable to the 
specific sensitization phenomena, since the anaemia and 
malnutrition of local areas of the skin is the ideal 
nidus for the action of toxic proteins, whether of 
bacterial or chemical origin. The reason for the selection 
of certain areas of the body for the exertion of this 
vasculotropic effect is that in those areas a congenital 
weakness does exist (Kyrie). They are analogous with the 
formation of multiple aneurysms, for while the vis a tergo 
factor in the production of these is admitted, it does 
not explain why that part of the artery wall should have 
been selected for the action of the syphilitic toxins. 
In the brief review of the literature presented 
above, the views of various observers are given in an 
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attempt to arrive at a working hypothesis of the causation 
of skin complications. The factors operating in the 
production of the dermatoses are either: (1) specific 
sensitivity of the body cells to the arsenical element 
of the various ccm pounds, or to the different radicals 
of which the compound is made up, and (2) the effect of 
infection upon the individual. 
Idiosyncracy to the drug or to the elements in its 
composition is a factor which might show itself in the 
skin or elsewhere in the body c.f. arsenic asthma. 
The effect of infection is a complex one, and the 
factors operating to produce this effect will be more 
easily understood when the lesions themselves are being 
considered. 
These factors are not alone the cause of a dermatosis 
for it is the summation of several elements which go to 
produce the lesion on the skin, in addition to certain 
predispositions on the part of the patient. 
The best summary of the theories advanced to explain 
the dermatoses is the work of Diasio (53) which he 
tabulates as follows: 
General or Systemic Factors. 
1. Lowered resistance to infections. 




3. Functional abnormalities, e.g. seborrhoea, 
etc. 
L.. Vascular injuries caused by the metal. 
5. Altered metabolism of the drug. 
64 Subnormality of other storage depots,. 
such as the liver. 
7. Presence of sensitizing products in- 
ducing a state of allergy. 
1. Irritation produced by external irritants, 
such as chemical agents applied to the 
skin, and occupational hazards. 
2. Irritation locally due to storage over- 
load of the arsenic. 
3. Localisation due to the presence of an 
independent dermatosis. 
A Review of 96 Cases of Arsenical Dermatitis, Occurring 
during Treatment for Syphilis at the Salford Municipal Clinic. 
In compiling this review it was felt that a mere 
record of the total number of injections during the time 
that they occurred would be unnecessary. It is not in- 
tended to give an appraisal of the toxicity of the various 
compounds used, nor the percentage of cases of dermatitis 
in a series of treated cases of syphilis. In the former, 
unless the patients are being treated exclusively with 
one drug any attempt to evaluate the toxicity is useless, 
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and percentages can mean anything or nothing. It is 
however, useful to know that the exhibition of a certain 
class of compound has a greater or less dermo -toxicity, 
and in this connexion the arsenicals are referred to as 
trivalent or pentavalent. 
Type of Arsenical Preparation and Relation to Dermo- Toxicity. 
No difference was noted in the incidence of derma- 
titis according to the type of preparation used, since 
both these classes of the arsenicals produced skin lesions. 
With stovarsol (a pentavalent arsenical given by 
mouth) dermatitis was observed in seven cases, and in five 
of these the eruptions developed during the administration 
of the drug. In two of these cases the trivalents had 
also been exhibited, but changed in one case because of 
prodromal symptoms of intolerance, and in the other, 
while the stovarsol did not have any ill -effects, change 
to sulpharsenol produced an eczematous lesion on the leg. 
Sulpharsenol was less frequently used than the other 
914 preparations, but it produced a greater incidence 
of skin intolerance. 16 cases were observed, and while 
the dermatitis developed during the actual exhibition 
of the drug in only four of these, we are of the opinion, 
in common with Belding and Goldman(%) and Fordyce, Rosen 
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and Myers (55) that this form of trivalent arsenical 
predisposes to the onset of dermatitis. The effect of 
sulpharsenol in bacterial infections is to produce a 
marked improvement in the condition. In gonococcal 
epididymitis and prostatitis, the exhibiton of this 
preparation is sometimes dramatic. It is assumed that 
the action is two -fold, partly a chemotherapeutic one, 
and partly the effect of protein shock. The latter may 
be effected either by stirring up the gonococcal focus 
to liberate more gonotoxin, or by tissue destruction 
at the site of injection with the production of a non- 
specific protein, which acts as a stimulant to antibody 
formation. It may be assumed that the chemotherapeutic 
part played by this drug is small, since the exhibition 
of other trivalent arsenicals by the intravenous route 
is not followed by any amelicaating effect (based on personal 
observations, to be published), and moreover it has not 
been noticed that in cases of gonorrhoea which are being 
treated co- existently with syphilis, that there is any 
shortening of the period during which the active gonorrhoea 
shows itself. It follows, therefore, that this preparation 
must exert its principal action by the stimulation of 
toxic foci to produce more toxin. The reaction of the 
healthy body is an equal and opposite one, with the 
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result that antibody (antitoxin) is formed. In a patient 
who has both a toxic focus and in whom there is the added 
effect of the depressant action of arsenic, it follows 
that lesions will develop at the point of maximum ir- 
ritation, namely in the skin, where a combination of 
forces, e.g. the seborrhoeic diathesis, or the deposition 
of arsenic where eli.aination by other routes is deficient, 
or local areas of diminished resistance, are in action. 
With the other arsenical compounds this overloading 
of the tissues must produce a constant depressant effect, 
which tends to permit unchecked the toxic action of 
bacterial poisons, whether acquired or inherent. 
Influence of the Stage of the Syphilis when Treat- 
ment was Commenced on the Occurrence of Dermatitis. 
The degrees of syphilis at this clinic are divided 
into eight groups, viz.: 
1. Sero -negative primary syphilis. 
2. Sero- positive primary syphilis. 
3 
4 
Sero- positive secondary 
early skin rash. 
Sero -positive secondary 
fading skin rash. 
syphilis, with 
syphilis, with 
5. Latent syphilis with no demonstrable lesions. 
6. Tertiary or Visceral syphilis. 
7. Neuro- syphilis. 
8. Congenital syphilis. 
In the first four degrees of syphilis, where the 
action of the syphilitic toxin is the cause of skin 
lesions, the incidence of dermatitis during treatment 
was no greater than in the later or tertiary (visceral 
and neuro- syphilis) and in congenital syphilis the lowest 
incidence of all was noted. The figures for the incidence 
of dermatitis are as follows: 
1. = 12.5% e.g. 12 cases 
2. s 12.5% a 12 " 
3 - 10.4% " 10 " 
4. r 12-5% 




In fact they show 84 remarkable uniformity. The 
"latent" degree of syphilis, where no demonstrable lesions 
due to the disease are present, shows the highest in- 
cidence, being twice as great as those where an early skin 
rash had developed. In this stage (5) the action of 
spirótoxin is not sufficient to cause a reaction, but yet 
the cutaneous tolerance to the arsenicals is less than 
5. =19.8% " 
6. = 12.5% " 
7. = 12.5% 
8. = 6.25% 
" 
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in the other types. These are patients in whom, while 
the disease processes are not sufficiently active to 
produce a suspension of function of vital organs, (liver, 
kidney, etc.) yet the additional strain of arsenic 
storage may be enough to cause a temporary suspension 
of their function, or at least to modify it. Yet since 
there was no increase in the incidence in the other late 
stages, it cannot be said that this is a factor which is 
of primary importance. 
It might be expected that in congenital syphilis (8) 
where the patient may be said to be in a state of super - 
saturation with treponemata, the effect of the killing 
of large numbers of the organisms would precipitate the 
effects of an added toxic substance, but Nabarro (56) has 
shown that children tolerate the arsenicals much better 
than adults, except where personal idiosyncracy exists, 
when they are just as liable to exfoliative complications. 
It can therefore be said that the onset of dermato- 
logical accidents is in no way comparable with the degree 
of the syphilis. 
Tlype of Skin Lesion and Factors Associated with their 
Production. 








































































































































































































































































































































































































































































1. Average number of injections given 
before the lesion appeared. 
. Whether treatment was resumed after the 
lesion had disappeared, or when it was 
felt that it was safe to do so, using the 
same agents. 
3. Whether the dermatitis recurred. 





e. Herpetiform (Zoster or Simplex). 
f. Other types e.g. Xerodermia, Seborrhoea, 
Pityriasis Rosea. 
g. Herxheimer (skin). 
It will be convenient to tabulate the "Reactions" 
under the three headings above, and it becomes immediately 
evident that except for the eczematous and exfoliative 
types, the others show a very strong resemblance to each 
other in the light of these headings. 
In certain cases treatment was not resumed with the 
same drug, as it was felt at the tizie that the element 
of risk was too great. 
With the exception of the "explosive" types of 
reaction, e.g. the exfoliative and the Herxheimer, it will 
be seen that no very great differences exist in the number 
of injections given before the onset of dermatitis. 
It is when one considers the results of resumption 
of treatment that the various types become of value as 
a guide to their causation. It will be noticed that in 
all the cases above, except the exfoliative, the eczema- 
tous, xerodermic, and seborrhoeic, treatment was resumed 
in the great majority without recurrence, and when this 
did occur, the lesion was repeated, and there was no 
tendency to the later development of exfoliative derma- 
titis. In the case of exfoliative dermatitis itself, 
while it is surprising that the average number of in- 
jections figure is so high, it can be explained by the 
inclusion of one case in whicn no less than 12 injections 
were given. That tnis condition may occur during the 
lst -3rd injection was noted by several observers, but in 
this series it was somewnat later. On the basis of 
induced hypersensitiveness this would be easily explained, 
as some time must elapse for the condition to develop. 
There are cases, however, in which there is an- apparently 
congenital predisposition to arsenical toxic reactions, 
and in these this develops with the first or second in- 
jection. 
The Xerodérmic and Seborrhoeic types are in all 
probability analogous to the eczematous, but the sebor- 
rhoeic factor in one and the peculiar dry, hard condition 
of the skin in the other were too pronounced to include 
them in that group. The results of continued treatment 
with arsenic was the same, as the majority of these 
lesions persisted, and tended only to become cured when 
arsenic was withheld. They never developed into the 
severe type. 
Included in the eczematous lesions was one uny 
doubted case of a "fixed exanthem ", who developed a 
seborrhoid after 10.35 grammes of trivalent arsenic, in 
22 injections. This lesion invariably showed an exa- 
cerbation with each arsenical injection, but always 
remained circumscribed and never showed any tendency to 
spread and involve other areas. Lees (in a personal 
communication) is of opinion that these are probably 
psadasis lesions, but their disappearance after cessation 
of treatment is proof of their specific nature, and 
arsenical in origin. The Herpetic lesions were with two 
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exceptions Zosteriform. In the true condition of herpes 
zoster, local prodromal signs are present, and it is 
assumed that a neuritis is an early sign. Certainly 
the great master of syphilology, Hutchinson, sought to 
establish the true toxic effect of arsenic upon the 
peripheral nerves and correlate the later appearance of 
herpes. In none of the cases under review were signs 
or symptoms of peripheral nerve involvement present. 
That peripheral neuritis does follow the exhibition of 
the arsenicals is indubitable, but there appears to be 
little or no connection between the onset of dermatitis 
and this complication. In three cases of neuritis prior 
to dermatitis, the types of lesion they preceded were 
erythema in two cases and the other was an exfoliative 
dermatitis. 
Robinson (57) in a review of postarsphenamine der - 
matitis found that the majority of patients (70%) gave 
a history of prodroma. In this series the number was 
5 (5.2 %). These were of the nature of pruritus 2.1 %, 
vasodilator 2.1 %, pains in the bones and in the joints 
1% each. Neither Kyrle nor Cannon and Karelitz believe 
that any relationship exists between the occurrence of 
prodroma and the onset of dermatitis, and from this they 
argue that they have no common origin. Nevertheless the 
fact that these conditions are present in cases under 
treatment with arsenic, and that they develop dermatitis 
at a later state must surely indicate that if they in 
themselves have no common origin, they are at least 
pointers to the instability of the patients' tolerance 
to arsenic. 
were: 
The types of lesion which they preceded 
1. Vasodilator Eczematous, and Xerodermia, 
which tends to support 
Kyrles view that the angio- 
neurotic patient (early 
nitritoid crisis) did not 
develop actue dermatitis. 
2. Pruritus Herpes Zoster, and Erythema. 
3. Bones Herpes Zoster. 
L. Joints Eczematous. 
The Herxheimer Reaction and its Relation to Dermatitis. 
Seven cases of cutaneous Herxheimer reaction were 
noted and:these developed on an average after the second 
injection. In every case treatment was resumed and in 
only one did a dermatosis develop at a later date, in 
the case of a "bad reactor" to the arsenobenzoles. 
The mechanism of the Herxheimer reaction is assumed 
to be the result of the sudden liberation of "spirotoxin" 
from large numbers of killed treponemata following an 
injection of arsenobenzole. The rash in secondary 
syphilis is the external evidence of an intense toxic 
process, each minute focus in the skin being the reaction 
around one or more of the actual organisms. The destruc- 
tion of these organisms and the liberation of spirotoxin 
would be expected to intensify the skin eruption, but 
it was observed that only one of the cases where a 
Herxheimer reaction developed was a "florid secondary" 
syphilide. Five were primary syphilis, and one was a 
latent case. The reaction is therefore a true pro- 
vocative one, and it has been repeatedly observed that 
the Serology, even in seronegative cases at the outset, 
almost invariably increases to give a positive result, 
after one or two injections. (Burke, in a personal 
communication.) The skin Herxheimer must therefore be 
analagous to the secondary rash, in that it is due to 
an increase in the amount of circulating "spirotoxin ". 
The serology in both is the same, as the body reacts 
with the production of lipo -protein reagent,whether it 
be a true antibody or a breakdown product of spirothaetal 
action on the tissues. We conclude by stating that there 
is no relationship between the occurrence of a Herxheimer 
reaction and later onset of dermatitis. 
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The Effect of Bismuth' in the Production of Dermatitis. 
AS a large number of cases in all groups had bismuth 
alternately with arsenobenzole, it is not possible to 
fix on the arsenical as the causa causans of the derma - 
toses. The toxic effect of bismuth is chiefly on the 
kidneys, and Stokes considers that skin lesions resulting 
from bismuth tnerapy are rare. In this series, twenty - 
seven cases of dermatitis occurred while the patient 
was receiving bismuth. The probable etiology is that 
the effect of the bismuth is to displace the arsenic, 
and where this is present in large amounts in any organ 
e.g. skin or liver, a greater toxic concentration is 
produced in the organ. Irritation of the surrounding 
cells then follows and so dermatitis is produced, and 
certain cases of jaundice. The jaundice in this case 
is the type of true toxic jaundice, where there is in- 
flammation and swelling of the hepatic cells, with in- 
crease in size of the liver. This is distinct from the 
most usual catarrhal type, due to a concurrent duodenitis- 
Relationship of Jaundice and Dermatitis. 
The majority of observers are agreed that no definite 
relationship is present between these two toxic manifes- 
tations. In one case jaundice and dermatitis were 
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co- existent, but in the majority, jaundice developed 
after the dermatitis, in 15.6% of the cases. Jaundice 
preceded the dermatitis in 3.1 %. At the same time there 
is present in some of these cases a definitely toxic 
element, and the effect is bound to be the creation of 
an added strain upon the hepatic function. This, however, 
can be grossly damaged without breaking down, but even- 
tually the "storage overload" becomes too much for it, 
elimination is forced more and more on to other organs 
and their inherent weaknesses are thus exposed. 
Previous Dermatoses and the Onset of Dermatitis. 
In 13.5% of the cases under review skin lesions 
were present before treatment was commenced, and only 
two subsequently developed dermatitis. In neither of 
these was the dermatitis compatible with direct arseno- 
benzole intolerance, one case incurring an impetiginous, 
the other an ecgematous skin eruption, neither of which 
persisted. 
Seasonal Incidence of Dermatitis. 
A factor which has been overlooked by all workers 
on this subject has been the seasonal one. They have 
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stressed the occupational factor, but this is one which 
can only have a remote bearing on the real cause of the 
condition, since in those trades where dermatitic hazards 
are operating, the mere fact that a patient is receiving 
injections of arsenic will not inflict him with a skin 
complication to the exclusion of his fellow- workers. The 
seasonal factor, however, has a distinct bearing upon 
skin respiration and it is the importance of this function 
which it is desired to stress. 
Where deficient elimination is present by the more 
rapid channels in the body, it is agreed that an added 
strain is thrown upon those whose action is not so 
spectacular. The skin respiration is the simplest 
physiological means of maintaining a healthy tone on 
the surface of the body, and where this is hampered, the 
natural discarding of dead epithelim, and the removal 
with it of irritant substances is retarded to such an 
extent that accumulation of these foreign substances 
occurs. It was observed in this series that in the 
Autumn and Winter months more skin complications occurred 
than in the Spring and Summer. The actual figures are: 
Autumn (September, October, November) 30.4% 
Winter (December, January, February) 32.6¡0 
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Spring (March, April, May) 
Summer (June, July and August) 
16.4% 
20.6% 
In the Winter months it is the custom for the in- 
habitants of these islands to clothe themselves to the 
fullest extent, and in addition the incentive to indulge 
in exercise and free movement is diminished. There is 
a definite tendency to hug the fire and spend as much 
time as possible within doors. The skin respiration is 
thereby damped down, and the accumulation of waste pro- 
ducts of all types, be they bacterial or arsenical, is 
encouraged. If to this is added any cause whereby 
elimination in other ways is also at a disadvantage the 
optimum conditions for irritation (mental or cutaneous) 
are produced. In the Spring there is d physiological 
resurgescence, and it is reflected again in a lower in- 
cidence of dermatitis, being half that of the preceding 
six months. The slight rise in Summer is due to the 
external influence of solar rays, and this is reflected 
in the onset of a severe erythematous dermatitis in a 
case receiving stovarsol, and involving the face, trunk, 
arms and less. It appears, therefore, that the free 
interchange of air at the skin surface is essential to 
maintain a healthy tone in this organ, with its constant 
stimulation to excretory activity. 
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As further proof that this surface respiratory and 
metabolic activity is of vital importance in the concep- 
tion of the etiology of the dermatosis, it has been 
shown by ivabarro (56) that children do not suffer so 
frequently from skin complications during treatment for 
syphilis. This may be attributed to the greater cutaneous 
metabolic activity of these ages, together with a free 
surface respiration, promoted by general muscular activity 
and the rapid metabolic processes. 
Conclusions. 
Dermatitis occurring during treatment with the 
arsenicals is therefore attributable to a variety of 
factors, or to the combination of several of them. 
Summarised, they are as follows: 
1. Exfoliative, an expression of a true antigen -antibody 
reaction, with the element of cutaneous sensitization 
due to a specific allergic response to arsenic. 
L. Predisposition; where the patient would have developed 
a dermatitis (given the requisite stimulus of trade 
hazards, emotion, drugs, foci of infection, etc.) in any 
case. These lesions are the approximation to the type 
of Erasmus Wilson, with symmetrical lesions, showing 
lichenification, weeping, etc. 
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3. Transient early erythemata, where after 5 -9 in- 
jections the patient develops a dermatitis, which after 
treatment never returns, and to whom arsenic may be 
given with impunity. These cases may be explained as 
the restoration in elimination - intake balance, or 
as the balance between an antigen- antibody reaction. 
L.. Failure of Elimination; where the dermatitis is 
the expression of the breakdown of one or more of the 
excretory organs of tne body. In all cases of over- 
loading of an excretory mechanism, the evidence of 
failure of function follows. The natural respiration 
the skin carries with it trie elimination of foreign 
substances, and the retention of this is bound to cause 
irritation. The type of eruption is merely an expression 
of the particular reaction of tne patient, their very 
multiplicity and diversity being a proof of this, for 
what in one patient would be a streptococcal fissure, 
in another it becomes an impetigo. 
The empirical use of such toxic drugs as arsenic 
is always bound to be followed by reactions, whether he 
be sensitive to the drug itself, or whether he be in 
addition the cockpit of a fierce bacterial war. Even 
to -day we are no nearer the discovery of the therapia 
sterilisans magna of Ehrlich, and in the meantime we 
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continue to use the tree -trunk of modern therapy to 
pick out the acarus which stands for the syphilitic 
process. We may destroy it wholly, but in so doing 
we are bruising the tissues of the host to such an 
extent that sometimes the last state of the patient 
is worse than the first. 
In no other disease more than syphilis is the 
aphorism that we are "treating a patient, not a disease" 
more true, for the action of the arsenicals is not 
primarily as a sterilising agent. The Treponema Pallidum 
exposed in vitro to the drugs are not materially affec- 
ted (Levaditi (58)) . It necessary that the living 
tissues combine with all or part of the drugs to produce 
from these comparatively inert substances a compound 
lethal to the organism, whether it be as the "arsenoxyl" 
of Levaditi, by oxidation and reduction as postulated 
by Voegtlin and Smith or by the abstraction of oxygen 
from the Treponema by the arsenobenzoles as Schumacher (59) 
has tried to show. Burke (60) has pointed out that the 
manufacture of the toxalbumens (arsenoxyl) throws a 
strain upon the producing- tissues of the patient, and it 
is evident that where this function is deficient, a 
quantity of unused drug is circulating in or being 
eliminated from the blood stream. The elimination of 
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arsenic can never be an indication of the effect of 
the drug upon the invading organisms, since the amount 
of combined arsenic in the tissues must remain for a 
varying length of time, until the body finally discards 
it, its work done. 
The future will give us a drug, a more rational 
equivalent to Ehrlich's effective sterilizing dose, 
which when introduced into the body produces an equal 
and opposite effect upon the invading organism, and each 
moiety will be utilised in the production of the effect 
for which it was intended, the final and complete de- 
struction of the Treponema Pallidum. 
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